Swertiamarin attenuates inflammation mediators via modulating NF-κB/I κB and JAK2/STAT3 transcription factors in adjuvant induced arthritis
- 25 February 2014
- journal article
- Published by Elsevier BV in European Journal of Pharmaceutical Sciences
- Vol. 56, 70-86
- https://doi.org/10.1016/j.ejps.2014.02.005
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytesArthritis Research & Therapy, 2013
- Effects of Swertia japonica extract and its main compound swertiamarin on gastric emptying and gastrointestinal motility in miceFitoterapia, 2011
- Inhibitory Potencies of Several Iridoids on Cyclooxygenase-1, Cyclooxygnase-2 Enzymes Activities, Tumor Necrosis Factor-α and Nitric Oxide ProductionIn VitroEvidence-Based Complementary and Alternative Medicine, 2010
- Cells of the synovium in rheumatoid arthritis. Synovial fibroblastsArthritis Research & Therapy, 2007
- (PS)2: protein structure prediction serverNucleic Acids Research, 2006
- Effect ofSemecarpus anacardium Linn. nut milk extract on rat neutrophil functions in adjuvant arthritisCell Biochemistry and Function, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic TargetThe Journal of Clinical Pharmacology, 1998
- Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritisArthritis & Rheumatism, 1995
- Interleukin-6: An OverviewAnnual Review of Immunology, 1990